A clinical pathway in breast cancer surgery: Pathway monitoring and impact. Geburtshilfe Frauenheilkd 2009; 69(7): 617-22. http://cat.inist.fr/?aModele=afficheN&cpsidt=21672222Richter-Ehrenstein C, Schneider A, Kramer M et al. A clinical pathway in breast cancer surgery: pathway ...
Clinical Preventive Service Recommendation: breast cancer. Accessed March 5, 2024. https://www.aafp.org/family-physician/patient-care/clinical-recommendations/all-clinical-recommendations/breast-cancer.html USPSTF Review: Screening for Breast Cancer JAMA US Preventive Services Task Force June 11, 2024 ...
Deployment of the AI algorithm as a real-time quality control system performing second reads (SR) in MHS commenced in December 2019 and is ongoing (Supplementary Fig.1a). The system was configured to raise two types of clinical alerts—invasive cancer alert, when the AI identifies an area sus...
Systems-wide profiling of breast cancer has almost always entailed RNA and DNA analysis by microarray and sequencing techniques. Marked developments in proteomic technologies now enable very deep profiling of clinical samples, with high identification an
It will be of great interest to observe how these and other novel therapeutic approaches targeted to the p53 pathway impact on clinical outcome in breast cancer.Abbreviations ASPP: = apoptosis stimulating protein of p53 A-T: = ataxia-telangectasia ATM: = ataxia-telangectasia mutated ATR: ...
Triple-negative breast cancer (TNBC) is the subtype of breast cancer that does not express the estrogen receptor or progesterone receptor and does not overexpress human epidermal growth factor 2. Of all breast cancer subtypes, it carries the worst prognosis and has limited treatment options. Metabol...
3. HER2-02 HER2-Low Status is Associated with Worse Clinical Outcomes in Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer Patients Treated With First-Line Cyclin-Dependent Kinase 4/6 Inhibitors Plus Endocrine Ther...
Breast cancer remains a significant scientific, clinical and societal challenge. This gap analysis has reviewed and critically assessed enduring issues and new challenges emerging from recent research, and proposes strategies for translating solutions into practice. Methods More than 100 internationally recogn...
advanced breast cancer algorithm endocrine hormone receptor positive postmenopausal treatment pathway Sorry, something went wrong. Please try again and make sure cookies are enabledreferences 1. H.J. Huang, P. Neven, M. Drijkoningen, et al. Association between tumour characteristics and HER-2/neu ...
One of the leading causes of death (20.1 per 100,000 women per year), breast cancer is the most prevalent cancer in females. Statistically, 95% of breast cancer are categorized as adenocarcinomas, and 55% of all patients may go into invasive phases; howe